Scott C. Brun - 29 May 2026 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Reporting relationship: Director
Issuer ticker: FBRX
Reported as of: 29 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2026, 16:36:04 UTC
Prior SEC filing: 03 Jul 2025
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact

Key filing fact

Scott C. Brun filed Form 4 for Forte Biosciences, Inc. (FBRX) on 02 Jun 2026.

Key facts

This page summarizes Scott C. Brun's Form 4 filing for Forte Biosciences, Inc. (FBRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jun 2026, 16:36.

Change

Previous filing in this sequence was filed on 03 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001863614 Primary reporting owner

Brun Scott C.

Relationship: Director
Address: C/O FORTE BIOSCIENCES, INC., 3060 PEGASUS PARK DR., BUILDING 6, DALLAS
Signature: /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Signature date: 02 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FBRX transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +18,353
Change %
Price: $0.000000^*
Shares after: 18,353
Date: 29 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,353
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. (the "Issuer") Common Stock.

Footnote F2

Subject to the Reporting Person's continuing as a Service Provider (as defined in the 2021 Equity Incentive Plan) through such date, one hundred percent (100%) of the RSUs subject to the award will vest on the date of the first annual meeting of the stockholders that occurs after May 29, 2026.